MicroRNA-7 inhibits multiple oncogenic pathways to suppress HER2Δ16 mediated breast tumorigenesis and reverse trastuzumab resistance
about
Autophagy and Apoptotic Crosstalk: Mechanism of Therapeutic Resistance in HER2-Positive Breast CancerAberrant Splicing of Estrogen Receptor, HER2, and CD44 Genes in Breast CancerRoles for miRNAs in endocrine resistance in breast cancerIdentification of Biomarkers for Breast Cancer Using Databases.Circular RNA participates in the carcinogenesis and the malignant behavior of cancer.miR-217 and CAGE form feedback loop and regulates the response to anti-cancer drugs through EGFR and HER2.A miRNA-based signature predicts development of disease recurrence in HER2 positive breast cancer after adjuvant trastuzumab-based treatment.miR-7 reverses the resistance to BRAFi in melanoma by targeting EGFR/IGF-1R/CRAF and inhibiting the MAPK and PI3K/AKT signaling pathways.MiRNA-based therapeutic intervention of cancer.Screening circular RNA related to chemotherapeutic resistance in breast cancer.The understanding of circular RNAs as special triggers in carcinogenesis.Circular RNA: a new star in neurological diseases.Involvement of microRNAs in HER2 signaling and trastuzumab treatment.Direct coupling of the HER4 intracellular domain (4ICD) and STAT5A signaling is required to induce mammary epithelial cell differentiation.Alternative Splicing in Breast Cancer and the Potential Development of Therapeutic Tools.Alternative-splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics.Functional miRNAs in breast cancer drug resistance.Advances in circular RNAs and their roles in breast CancerHER2 inhibition in gastro-oesophageal cancer: A review drawing on lessons learned from breast cancer
P2860
Q26753162-0B7A6E0C-9049-4797-806B-DD26629EF431Q26773907-DEAA294F-E7B8-495E-8370-C11A304D227DQ26783076-906E33C4-996B-4276-8636-85ED9CCEB40AQ30239810-B0D53E0E-8697-4C98-9728-538C88FB259CQ33739727-C2CD86D4-6A8B-4059-BCC1-EB050CC8FECBQ36962950-B1D9DE7F-3E39-4348-AB3B-7705E14E13A9Q37271711-F3721AD7-EFBE-4529-9ADD-6636EBC3E795Q37619788-D63D266C-DD5C-43E2-83AF-66E940BED6A8Q38524274-95D1B402-E4BD-4A76-B5D7-58FA73095E54Q38627238-17B9D5B1-B610-442E-A8F1-983B3AB34E67Q38732302-23536F8E-5BED-425E-BD69-AEC758DAB90BQ38952296-371C3C9A-5E97-472D-B7E7-1991221A84F8Q38979308-BE1A69F2-E3C6-4DD3-9003-DCCEF4D9F11FQ41682816-CE461360-A780-4FA4-B3A0-3CDE697975C2Q47110708-1F3DFD08-7A97-4600-AE30-0E4DEE573815Q52564290-BC422918-D98A-41BD-A10B-6D623E37AF46Q55000578-FEEC4152-D2A0-4436-B046-3E2F49A7AE8EQ57107429-B9481C81-1B7E-4E08-8E16-3B350E9D9AE1Q57109545-08C9A441-0F87-408D-8D00-D4C34F80AC38
P2860
MicroRNA-7 inhibits multiple oncogenic pathways to suppress HER2Δ16 mediated breast tumorigenesis and reverse trastuzumab resistance
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
MicroRNA-7 inhibits multiple o ...... reverse trastuzumab resistance
@ast
MicroRNA-7 inhibits multiple o ...... reverse trastuzumab resistance
@en
MicroRNA-7 inhibits multiple o ...... reverse trastuzumab resistance
@nl
type
label
MicroRNA-7 inhibits multiple o ...... reverse trastuzumab resistance
@ast
MicroRNA-7 inhibits multiple o ...... reverse trastuzumab resistance
@en
MicroRNA-7 inhibits multiple o ...... reverse trastuzumab resistance
@nl
prefLabel
MicroRNA-7 inhibits multiple o ...... reverse trastuzumab resistance
@ast
MicroRNA-7 inhibits multiple o ...... reverse trastuzumab resistance
@en
MicroRNA-7 inhibits multiple o ...... reverse trastuzumab resistance
@nl
P2860
P1433
P1476
MicroRNA-7 inhibits multiple o ...... reverse trastuzumab resistance
@en
P2093
Felicia C Huynh
Frank E Jones
P2860
P304
P356
10.1371/JOURNAL.PONE.0114419
P407
P577
2014-12-22T00:00:00Z